Houston, TX, March 22, 2021 - Audubon Bioscience has become a proud member of the Personalized Medicine Coalition (PMC). This membership will focus on advocating and educating the medical community as well as the general public on the importance of precision medicine for public health.
Located in the US, the Personalized Medicine Coalition represents innovators, scientists, patients, providers and payers, and serves to promote the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems.
“We are honored to welcome Audubon Bioscience as a member of the Personalized Medicine Coalition and look forward to its assistance in our effort to advance personalized medicine through education, advocacy, and evidence development,” said PMC President Edward Abrahams.
“We are thrilled to become members of the Personalized Medicine Coalition. We look forward to joining forces together in learning and collaborating with other expert members,” said Audubon’s CEO, Dr. Rostyslav Semikov. “Our initial actions will focus on disseminating PMC’s reports and educational materials to doctors across our global network and on serving on the Coalition’s committees and working groups working towards evidence-based advocacy of precision medicine.”
This move is part of Audubon’s strategy of partnering with experts in the field and contributing to the understanding and implementation of precision medicine as standard medical care.
If you would like more information or a comment from our top-management, please contact our PR department at [email protected].
To learn more about Audubon Bioscience’s service offering, click here.